Additional file 1: of A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)

Meindl-Beinker, Nadja; Betge, Johannes; Gutting, Tobias; Burgermeister, Elke; Belle, Sebastian; Zhan, Tianzuo; Schulte, Nadine; Maenz, Martin; Ebert, Matthias; Haertel, Nicolai

doi:10.6084/m9.figshare.7849832.v1

12885_2019_5446_MOESM1_ESM.docx (37.61 kB)

Additional file 1: of A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)

journal contribution

posted on 2019-03-14, 05:00 authored by Nadja Meindl-Beinker, Johannes Betge, Tobias Gutting, Elke Burgermeister, Sebastian Belle, Tianzuo Zhan, Nadine Schulte, Martin Maenz, Matthias Ebert, Nicolai Haertel

Table S1. RAMONA. Title of data: RAMONA synopsis. Description of data: synopsis of the RAMONA trial. (DOCX 37 kb)

Funding

History

Usage metrics

Keywords

Esophageal squamous cell cancer Elderly Comprehensive geriatric assessment Checkpoint inhibitors Personalized medicine Geriatric oncology

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)

Funding

sponsored by AIO-Studien gGmbH funded by BMS

History

Usage metrics

Categories

Keywords

Licence

Exports